Skip to main content
Carolyn Mulroney, MD, Oncology, Las Vegas, NV

Carolyn Marie Mulroney MD


Associate Clinical Professor, Medicine, Blood and Marrow Transplant, UCSD School of Medicine

Join to View Full Profile
  • 3150 N Tenaya WaySte 520Las Vegas, NV 89128

  • Phone+1 702-962-2100

  • Fax+1 858-822-6844

Dr. Mulroney is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • University of California (San Francisco)
    University of California (San Francisco)Fellowship, Hematology and Medical Oncology, 1990 - 1992
  • University of Washington
    University of WashingtonFellowship, Hematology and Medical Oncology, 1989 - 1990
  • Duke University Hospital
    Duke University HospitalResidency, Internal Medicine, 1986 - 1990
  • Johns Hopkins University School of Medicine
    Johns Hopkins University School of MedicineClass of 1986
  • University of Pennsylvania
    University of PennsylvaniaBA, Biochemistry, 1978 - 1982

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1990 - 2025
  • NV State Medical License
    NV State Medical License 2024 - 2025
  • NC State Medical License
    NC State Medical License 1989 - 1990
  • WA State Medical License
    WA State Medical License 1989 - 1990
  • Hematology
    American Board of Internal Medicine Hematology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Clinical Trials

Publications & Presentations

Abstracts/Posters

  • Phase II Study of the Combination of Daratumumab, Ixazomib, Pomalidomide, and Dexamethasone As Salvage Therapy in Relapsed/Refractory Multiple Myeloma: Results of a Sa...
    Carolyn Mulroney, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Phase II Study of the Combination of Daratumumab, Ixazomib, Pomalidomide, and Dexamethasone As Salvage Therapy in Relapsed/Refractory Multiple Myeloma: Results of a Sa...
    Carolyn Mulroney, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: